On the public citation graph

Dual-Responsive Core–Shell Tecto Dendrimers Enable Efficient Gene Editing of Cancer Cells to Boost Immune Checkpoint Blockade Therapy

https://doi.org/10.1021/acsami.2c22584
0 signed · 81 inferred · view as graph

Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.

Is this your work? Sign in with ORCID and put your name on the claims that are yours.
Claim with ORCID
Reference health. See whether every reference in this work resolves to a known work and none has been retracted — and get a dated CiteStamped badge you can embed.
See reference health

What this work says

Outgoing claims: the papers this work cites, builds on, or argues with.

inferredcites →https://doi.org/10.1002/adfm.201703036openalex-snapshot
Targeted Delivery of CRISPR/Cas9‐Mediated Cancer Gene Therapy via Liposome‐Templated Hydrogel Nanoparticles
inferredcites →https://doi.org/10.1002/adfm.202004940openalex-snapshot
Multistage Sensitive NanoCRISPR Enable Efficient Intracellular Disruption of Immune Checkpoints for Robust Innate and Adaptive Immune Coactivation
inferredcites →https://doi.org/10.1002/adfm.202100227openalex-snapshot
Multi‐Responsive Biodegradable Cationic Nanogels for Highly Efficient Treatment of Tumors
inferredcites →https://doi.org/10.1002/adma.201905751openalex-snapshot
Dual‐Locking Nanoparticles Disrupt the PD‐1/PD‐L1 Pathway for Efficient Cancer Immunotherapy
inferredcites →https://doi.org/10.1002/adma.202104641openalex-snapshot
Sono‐Controllable and ROS‐Sensitive CRISPR‐Cas9 Genome Editing for Augmented/Synergistic Ultrasound Tumor Nanotherapy
inferredcites →https://doi.org/10.1002/advs.202100165openalex-snapshot
Intelligent Molybdenum Disulfide Complexes as a Platform for Cooperative Imaging‐Guided Tri‐Mode Chemo‐Photothermo‐Immunotherapy
inferredcites →https://doi.org/10.1002/advs.202100292openalex-snapshot
Programmable Unlocking Nano‐Matryoshka‐CRISPR Precisely Reverses Immunosuppression to Unleash Cascade Amplified Adaptive Immune Response
inferredcites →https://doi.org/10.1002/anie.201203360openalex-snapshot
A Phenylboronate‐Functionalized Polyion Complex Micelle for ATP‐Triggered Release of siRNA
inferredcites →https://doi.org/10.1002/smll.202004879openalex-snapshot
Photo‐Enhanced CRISPR/Cas9 System Enables Robust PD‐L1 Gene Disruption in Cancer Cells and Cancer Stem‐Like Cells for Efficient Cancer Immunotherapy
inferredcites →https://doi.org/10.1007/s00262-021-03107-yopenalex-snapshot
The integration of systemic and tumor PD-L1 as a predictive biomarker of clinical outcomes in patients with advanced NSCLC treated with PD-(L)1blockade agents
inferredcites →https://doi.org/10.1007/s11426-019-9699-3openalex-snapshot
Responsive boron biomaterials and their biomedical applications
inferredcites →https://doi.org/10.1007/s12274-019-2465-xopenalex-snapshot
Nanotechnology based CRISPR/Cas9 system delivery for genome editing: Progress and prospect
inferredcites →https://doi.org/10.1007/s40843-020-1591-1openalex-snapshot
Gene silencing-mediated immune checkpoint blockade for tumor therapy boosted by dendrimer-entrapped gold nanoparticles
inferredcites →https://doi.org/10.1016/j.addr.2019.11.005openalex-snapshot
Rational designs of in vivo CRISPR-Cas delivery systems
inferredcites →https://doi.org/10.1016/j.addr.2020.03.001openalex-snapshot
Synthetic multi-layer nanoparticles for CRISPR-Cas9 genome editing
inferredcites →https://doi.org/10.1016/j.addr.2020.04.010openalex-snapshot
Delivery of CRISPR/Cas systems for cancer gene therapy and immunotherapy
inferredcites →https://doi.org/10.1016/j.biomaterials.2015.10.022openalex-snapshot
Phenylboronic acid-sugar grafted polymer architecture as a dual stimuli-responsive gene carrier for targeted anti-angiogenic tumor therapy
inferredcites →https://doi.org/10.1016/j.biomaterials.2018.04.031openalex-snapshot
Non-viral delivery systems for CRISPR/Cas9-based genome editing: Challenges and opportunities
inferredcites →https://doi.org/10.1016/j.biomaterials.2020.120194openalex-snapshot
Chlorin e6 and CRISPR-Cas9 dual-loading system with deep penetration for a synergistic tumoral photodynamic-immunotherapy
inferredcites →https://doi.org/10.1016/j.biomaterials.2020.120275openalex-snapshot
Virus-like nanoparticle as a co-delivery system to enhance efficacy of CRISPR/Cas9-based cancer immunotherapy
inferredcites →https://doi.org/10.1016/j.biomaterials.2021.120798openalex-snapshot
A novel therapeutic modality using CRISPR-engineered dendritic cells to treat allergies
inferredcites →https://doi.org/10.1016/j.immuni.2013.07.012openalex-snapshot
Oncology Meets Immunology: The Cancer-Immunity Cycle
inferredcites →https://doi.org/10.1016/j.jconrel.2017.09.012openalex-snapshot
Delivery strategies of the CRISPR-Cas9 gene-editing system for therapeutic applications
inferredcites →https://doi.org/10.1016/j.jconrel.2017.09.013openalex-snapshot
Cancer-derived exosomes as a delivery platform of CRISPR/Cas9 confer cancer cell tropism-dependent targeting
inferredcites →https://doi.org/10.1016/j.nantod.2019.100801openalex-snapshot
Recent advances in nanosized drug delivery systems for overcoming the barriers to anti-PD immunotherapy of cancer
inferredcites →https://doi.org/10.1016/j.nantod.2021.101083openalex-snapshot
pH/ATP cascade-responsive nano-courier with efficient tumor targeting and siRNA unloading for photothermal-immunotherapy
inferredcites →https://doi.org/10.1016/j.trecan.2021.11.009openalex-snapshot
Tumor immunology CRISPR screening: present, past, and future
inferredcites →https://doi.org/10.1021/acsabm.0c01525openalex-snapshot
Multifunctional Core–Shell Tecto Dendrimers Incorporated with Gold Nanoparticles for Targeted Dual Mode CT/MR Imaging of Tumors
inferredcites →https://doi.org/10.1021/acsami.5b11866openalex-snapshot
Sialic Acid-Targeted Nanovectors with Phenylboronic Acid-Grafted Polyethylenimine Robustly Enhance siRNA-Based Cancer Therapy
inferredcites →https://doi.org/10.1021/acsami.8b13291openalex-snapshot
Reactive Oxygen Species (ROS)-Responsive Charge-Switchable Nanocarriers for Gene Therapy of Metastatic Cancer
inferredcites →https://doi.org/10.1021/acsbiomaterials.0c01190openalex-snapshot
Design Strategies and Applications of ROS-Responsive Phenylborate Ester-Based Nanomedicine
inferredcites →https://doi.org/10.1021/acsnano.2c01885openalex-snapshot
HSP70-Promoter-Driven CRISPR/Cas9 System Activated by Reactive Oxygen Species for Multifaceted Anticancer Immune Response and Potentiated Immunotherapy
inferredcites →https://doi.org/10.1021/ja406406hopenalex-snapshot
Phenylboronic Acid-Installed Polymeric Micelles for Targeting Sialylated Epitopes in Solid Tumors
inferredcites →https://doi.org/10.1039/c6tb00710dopenalex-snapshot
Partially PEGylated dendrimer-entrapped gold nanoparticles: a promising nanoplatform for highly efficient DNA and siRNA delivery
inferredcites →https://doi.org/10.1039/c7tb02585hopenalex-snapshot
Construction of core–shell tecto dendrimers based on supramolecular host–guest assembly for enhanced gene delivery
inferredcites →https://doi.org/10.1039/c9nr08309jopenalex-snapshot
Core–shell tecto dendrimers formed via host–guest supramolecular assembly as pH-responsive intelligent carriers for enhanced anticancer drug delivery
inferredcites →https://doi.org/10.1039/d0tb00346hopenalex-snapshot
Efficient co-delivery of microRNA 21 inhibitor and doxorubicin to cancer cells using core–shell tecto dendrimers formed via supramolecular host–guest assembly
inferredcites →https://doi.org/10.1126/sciadv.abc9450openalex-snapshot
CRISPR-Cas9 genome editing using targeted lipid nanoparticles for cancer therapy
inferredcites →https://doi.org/10.18632/oncotarget.16326openalex-snapshot
Targeting programmed cell death ligand 1 by CRISPR/Cas9 in osteosarcoma cells
inferredcites →https://doi.org/10.2217/nnm-2018-0522openalex-snapshot
Application of Nanoparticle-Based siRNA and CRISPR/Cas9 Delivery Systems in Gene-Targeted Therapy
inferredcites →https://doi.org/10.7150/thno.35568openalex-snapshot
RNA Nanotechnology-Mediated Cancer Immunotherapy
inferredcites →https://doi.org/10.7150/thno.47007openalex-snapshot
Strategies in the delivery of Cas9 ribonucleoprotein for CRISPR/Cas9 genome editing

What points at this work

Incoming claims: where this work appears in other papers’ reference lists and arguments.

inferred← citeshttps://doi.org/10.2139/ssrn.4880526openalex-extracted
Specific and Ultrasensitive Fluorescence Detection of Ampicillin Based on Water-Soluble Au(I) Complexes Catalysed Hydrolysis
inferred← citeshttps://doi.org/10.1002/adfm.75118openalex-snapshot
Multi‐Responsive Dendrimer‐Hyaluronic Acid Hydrogel With Lubricating and Immunoregulatory Functions for Synergistic Osteoarthritis Therapy
inferred← citeshttps://doi.org/10.1002/adfm.78378openalex-snapshot
Engineering Metal Nanomaterials for Precision Genetic Medicine
inferred← citeshttps://doi.org/10.1002/marc.202400251openalex-snapshot
Structural and Property Characterizations of Dual‐Responsive Core–Shell Tecto Dendrimers for Tumor Penetration and Gene Delivery Applications
inferred← citeshttps://doi.org/10.1002/smll.202411787openalex-snapshot
Activatable Molecular Probes With Clinical Promise for NIR‐II Fluorescent Imaging
inferred← citeshttps://doi.org/10.1007/s11426-025-2737-5openalex-snapshot
Exosome-coated responsive dendrimer nanogels enable combined immunomodulation and antioxidant treatment of acute lung injury
inferred← citeshttps://doi.org/10.1007/s12668-026-02783-3openalex-snapshot
Dendrimer-Based Nanoplatforms for Cancer Diagnosis and Therapy: from Liquid Biopsy to Targeted Protein Degradation
inferred← citeshttps://doi.org/10.1016/b978-0-443-44585-9.00014-7openalex-snapshot
Dendrimers: Promising nanocarriers for targeted delivery in lung cancer treatment
inferred← citeshttps://doi.org/10.1016/j.actbio.2025.06.021openalex-snapshot
A biomimetic nanoplatform mediates hypoxia-adenosine axis disruption and PD-L1 knockout for enhanced MRI-guided chemodynamic-immunotherapy
inferred← citeshttps://doi.org/10.1016/j.advim.2025.100002openalex-snapshot
Dendrimer-based nanoplatforms for enhanced mRNA delivery: From rational structural design to formulation strategies
inferred← citeshttps://doi.org/10.1016/j.cis.2024.103301openalex-snapshot
Phenylboronic acid-functionalized biomaterials for improved cancer immunotherapy via sialic acid targeting
inferred← citeshttps://doi.org/10.1016/j.heliyon.2024.e39323openalex-snapshot
Emerging Gene-editing nano-therapeutics for Cancer
inferred← citeshttps://doi.org/10.1016/j.ijbiomac.2025.148389openalex-snapshot
CRISPR/Cas9 gene editing strategy for cancer therapy: non-viral nanocarrier-mediated delivery of plasmids, RNA and ribonucleoprotein complexes
inferred← citeshttps://doi.org/10.1016/j.ijbiomac.2026.150582openalex-snapshot
CRISPR/Cas9 genome editing-based preclinical theranostics, biomarkers and drug delivery systems for cancer applications
inferred← citeshttps://doi.org/10.1016/j.jconrel.2023.08.028openalex-snapshot
CRISPR/Cas9-based application for cancer therapy: Challenges and solutions for non-viral delivery
inferred← citeshttps://doi.org/10.1016/j.jconrel.2025.113780openalex-snapshot
Targeted eradication of glioblastoma via venom decapeptide-conjugated dendrimers: Inducing nuclear translocation and autophagic cell death
inferred← citeshttps://doi.org/10.1016/j.jddst.2025.107705openalex-snapshot
CRISPR/Cas9-integrated nanocarriers for cancer gene therapy: Mechanistic insights, challenges, and clinical translation
inferred← citeshttps://doi.org/10.1016/j.omtn.2025.102457openalex-snapshot
Advanced delivery systems for gene editing: A comprehensive review from the GenE-HumDi COST Action Working Group
inferred← citeshttps://doi.org/10.1021/acs.chemmater.3c01151openalex-snapshot
Targeted Delivery of Anticancer Therapeutics with Polymers by Harnessing Tumor Microenvironment Acidity
inferred← citeshttps://doi.org/10.1021/acs.molpharmaceut.5c00251openalex-snapshot
Development of Inorganic and Hybrid Nanosystems for Delivery of CRISPR-Based Gene Editors
inferred← citeshttps://doi.org/10.1021/acsami.4c05311openalex-snapshot
Nordihydroguaiaretic Acid-Cross-Linked Phenylboronic Acid-Functionalized Polyplex Micelles for Anti-angiogenic Gene Therapy of Orthotopic and Metastatic Tumors
inferred← citeshttps://doi.org/10.1038/s41570-026-00855-2openalex-snapshot
Precision chemical engineering of dendrimers for nucleic acid delivery
inferred← citeshttps://doi.org/10.1038/s41578-024-00725-7openalex-snapshot
CRISPR–Cas9 delivery strategies for the modulation of immune and non-immune cells
inferred← citeshttps://doi.org/10.1039/d3bm01198dopenalex-snapshot
Phosphorus core–shell tecto dendrimers for enhanced tumor imaging: the rigidity of the backbone matters
inferred← citeshttps://doi.org/10.1039/d3sd00101fopenalex-snapshot
Recent advances in PAMAM dendrimer-based CT contrast agents for molecular imaging and theranostics of cancer
inferred← citeshttps://doi.org/10.1039/d4bm00286eopenalex-snapshot
Non-viral vector-based genome editing for cancer immunotherapy
inferred← citeshttps://doi.org/10.1039/d4py00124aopenalex-snapshot
Recent developments of polymeric delivery systems in gene therapeutics
inferred← citeshttps://doi.org/10.1039/d5pm00083aopenalex-snapshot
Phenylboronic acid derivatives: advancing glucose-responsive insulin delivery and multifunctional biomedical applications
inferred← citeshttps://doi.org/10.1097/scs.0000000000013025openalex-snapshot
Nanomaterials in Melanoma Immunotherapy: A 20-Year Bibliometric and Visualization Analysis
inferred← citeshttps://doi.org/10.1134/s1068162025603179openalex-snapshot
Recent Advances in Dendrimers as Potential Therapeutic Delivery Systems
inferred← citeshttps://doi.org/10.1186/s12943-023-01925-5openalex-snapshot
Comprehensive review of CRISPR-based gene editing: mechanisms, challenges, and applications in cancer therapy
inferred← citeshttps://doi.org/10.1186/s12964-025-02610-4openalex-snapshot
Advanced nanotechnology in enhancing immune checkpoint inhibitors (ICIs) for head and neck cancer therapy
inferred← citeshttps://doi.org/10.2147/dddt.s517331openalex-snapshot
Stimuli-Responsive Drug Delivery Systems for Enhanced Melanoma Immunotherapy
inferred← citeshttps://doi.org/10.2147/ijn.s595199openalex-snapshot
Drug Delivery Engineering Strategies Targeting CD4+/CD8+ T Cell Exhaustion to Improve the Tumor Immunosuppressive Microenvironment
inferred← citeshttps://doi.org/10.2217/nnm-2023-0124openalex-snapshot
Dendrimer-Mediated Gene Delivery to Boost Cancer Immunotherapy
inferred← citeshttps://doi.org/10.3389/fphar.2023.1059343openalex-snapshot
Recent advances in nanoparticle applications in respiratory disorders: a review
inferred← citeshttps://doi.org/10.3390/jnt7010006openalex-snapshot
Nano-Enabled CRISPR-Cas Gene Editing for Cancer Therapeutics
inferred← citeshttps://doi.org/10.3390/nano15070540openalex-snapshot
Precisely Targeted Nanoparticles for CRISPR-Cas9 Delivery in Clinical Applications
inferred← citeshttps://doi.org/10.34133/bmr.0086openalex-snapshot
Inorganic Nanoparticle Functionalization Strategies in Immunotherapeutic Applications
Editorial review for independent work. ICSAC — the Institute for Complexity Science and Advanced Computing — runs a structured editorial panel for researchers publishing outside journals, and publishes on CiteStamp rails. Submission is free and goes through ORCID: icsacinstitute.org/submit.